Public Joint-Stock Company "Pharmsynthez" (LIFE) Stock Overview

Public Joint-Stock Company "Pharmsynthez", a pharmaceutical company, researches, manufactures, and distributes officinal and generic active pharmaceutical ingredients in Russia, Europe, the United States, and CIS countries. The company offers officinal medicines, including Neovir, Segidrin, Glaumax, Vazostenon, Neostim, Fludarabel, Fenazide, Fenasid, and Penkrofton that are used in oncology, gynecology, treatment of immune deficiencies, and tuberculosis. Public Joint-Stock Company "Pharmsynthez" was founded in 1996 and is based in St. Petersburg, Russia.